These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3229037)

  • 1. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
    Serri O; Beauregard H; Somma M; Comtois R; Jilwan N; Hardy J
    Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine regulation of prolactin and TSH secretion in hypothyroidism.
    Gerasimov G; Chernova T; Goncharov N
    Acta Med Austriaca; 1992; 19 Suppl 1():86-8. PubMed ID: 1519463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia associated with chronic renal failure in the rat.
    Torres-Noriega J; Frohman LA
    Horm Metab Res; 1986 Apr; 18(4):241-3. PubMed ID: 3710420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma.
    Quigley ME; Judd SJ; Gilliland GB; Yen SS
    J Clin Endocrinol Metab; 1980 Jun; 50(6):994-8. PubMed ID: 7372794
    [No Abstract]   [Full Text] [Related]  

  • 6. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
    Seki K; Kato K; Shima K
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine infusion enhances the adrenocorticotropic hormone and cortisol response to metoclopramide in hyperprolactinemic patients but not in normal subjects.
    Moro M; Maraschini C; Cavagnini F
    Gynecol Endocrinol; 1997 Jun; 11(3):155-62. PubMed ID: 9209895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis].
    Mychka VB; Chazova IE; Dmitriev VV; Masenko VP
    Ter Arkh; 2000; 72(9):10-3. PubMed ID: 11076407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia.
    Serri O
    Horm Res; 1987; 27(1):36-41. PubMed ID: 3623428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME; Judd SJ; Gilliland GB; Yen SS
    J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
    Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG
    Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
    Petraglia F; De Leo V; Nappi C; Facchinetti F; Montemagno U; Brambilla F; Genazzani AR
    J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin circadian rhythm in women with idiopathic hyperprolactinemia.
    Karasek M; Stawerska R; Hilczer M; Zylinska K; Lewinski A
    Neuro Endocrinol Lett; 2004 Dec; 25(6):411-4. PubMed ID: 15665801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoclopramide challenge: a measure of human lactotroph activity.
    Martin RH
    Obstet Gynecol; 1983 Dec; 62(6):691-5. PubMed ID: 6633994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
    Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
    Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin response to perphenazine. A sensitive and specific test for pituitary tumor in hyperprolactinemic women.
    Mattox JH; Fortunato SJ
    J Reprod Med; 1986 Dec; 31(12):1098-101. PubMed ID: 3795197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin release in polycystic ovary.
    Falaschi P; del Pozo E; Rocco A; Toscano V; Petrangeli E; Pompei P; Frajese G
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prolactin and TSH response in functional tests in patients with primary hypothyroidism in a context of hyperprolactinemia].
    Chernova TO; Kolesnikova GS; Mudretsova SV; Serpukhovitin SIu; Goncharov NP; Gereasimov GA
    Probl Endokrinol (Mosk); 1994; 40(5):16-8. PubMed ID: 7899431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pregnancy in hyperprolactinemic patients].
    Ventz M; Puhlmann B; Knappe G; Gerl H; Lehmann R; Rohde W
    Zentralbl Gynakol; 1996; 118(11):610-5. PubMed ID: 9082694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.